Creative Biogene Developed A Large Collection of Kinase Stable Cell Lines for In Vitro Cell-based Kinase Assays
Recently, Creative Biogene announced the launch of a large collection of kinase stable cell lines that can be applied for human physiology and disease research.
New York, United States – December 15, 2020 /MarketersMedia/ —
Creative Biogene, as a scientists-founded and scientists-driven leading biotechnological company, has focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences research, biomedical development, industrial synthetic application and preclinical drug discovery. Recently, Creative Biogene announced the launch of a large collection of kinase stable cell lines that can be applied for human physiology and disease research.
Kinases are related to many complex cellular pathways, including cell metabolism, cell signal transduction, cell transport, etc., which make them very important for human physiology. Because many kinases can enhance cell proliferation, cell migration and cell survival, loss of function or gain-of-function mutations in kinases can lead to various types of cancer and certain human immune, neurological and infectious diseases.
Due to the important cellular functions, kinases have become an important drug target in drug discovery and development for the treatment of human diseases, especially a variety of cancers. These targets include epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), erb-b2 receptor tyrosine kinase 2 (ERBB2), platelet-derived Growth factor receptor (PDGFR), kit, ABL, SRC, mTOR, etc. Small molecule kinase inhibitors targeting these targets have played an important role in the treatment of many cancers.
Creative Biogene has developed a large number of kinase stable cell lines that can be used for in vitro cell-based kinase assays. The use of these cell lines allows for a wide range of assays and reduces assay development time.The supported cell line includes but not limited to EGFR cell line, BCR-ABL cell line, AXL cell line, BTK cell line, C-Kit cell line, EML4-ALK cell line, ETV6-NTRK2 cell line etc.
Among these cell lines, Ba/F3 Cell Line has become a popular system in kinase drug discovery as it can grow at a fast speed, which can speed up the experiment time, and is suitable as a host for transfection or transduction. When BaF3 constitutively expresses active tyrosine kinase through cell engineering, it becomes IL-3 independent. The BaF3 stable cell line provided by Creative Biogene is constructed by stably delivering the foreign human BCR-ABL and BCR-ABL-T315I coding sequences into the genome of BaF3 cells mediated by retroviruses. Western blot analysis showed that BCR-ABL and BCR-ABL-T315I were significantly overexpressed in the cell lines.
“Ba/F3 is a murine interleukin 3 dependent pro-B cell line, which is a popular system for exploring kinases and their kinase inhibitors, because some protein kinases can make Ba/F3 cells independent of IL-3, and their inhibitors counteract this effect.” said Marcia Brady, the marketing director of Creative Biogene, she also said, “Our scientists have many years of experience in achieving gene overexpression stable cell lines covering GPCR, reporter gene and ion channel stable cell lines.”
About Creative Biogene
Creative Biogene, as a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.
Contact Info:
Name: Marcia Brady
Email: Send Email
Organization: Creative Biogene
Address: New York, 11967, USA
Phone: 16316197922
Website: https://www.creative-biogene.com/
Source: MarketersMedia
Release ID: 88989723
Copyright © 1999-2013 SproutNews.com
